NCT06089161 · RECRUITING
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
This trial tests whether a personalized coaching model called PRAISE helps Black adults with sleep apnea stick to their CPAP or PAP treatment. Researchers will then measure whether better sleep apnea treatment affects Alzheimer's disease biomarkers and cognitive performance. This is a Phase NA behavioral study, meaning it is testing a care approach rather than a drug, and results are not yet established.
You may qualify if
- Self-reported race/ethnicity as African American, African, Caribbean or black
- Ages 60-85 years
- accessible by phone
- OSA diagnosis
- consent, including permission to release medical data
You're excluded if
- progressive illnesses in which disability or death is expected within 1 year
- impaired cognitive/ functional ability precluding participation
- intention to move within the year
- and a family member currently enrolled.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-05-08